ArticleJACC. Case reports2026
Bicuspid Aortic Valve Aortopathy in an Athlete: A Case Report and Mini-Review.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBicuspid aortic valve (BAV) is a common congenital condition associated with progressive aortopathy and remains a frequent justification for sporting restriction despite limited data on exercise-related aortic events. CASE SUMMARY: An asymptomatic 18-year-old athlete undergoing evaluation for military service was discovered to possess a type-1 BAV, accompanied by a dilated aortic root (4.2-4.3 cm), with trivial to mild aortic regurgitation. Serial imaging demonstrated rapid progression of aortic dilatation to 4.7 cm. Such findings posed significant implications for military eligibility and athletic participation. Consequently, given long-term aspirations for athletic and military participation, a valve-sparing aortic root replacement was performed. REVIEW SUMMARY: BAV-associated aortopathy in athletes requires a personalized risk assessment, careful surveillance, and shared decision-making. Despite conservative historical guidelines, the risk of exercise-related aortic dissection is low, and individualized management, including prompt surgical intervention, may allow safe return to athletic participation. TAKE-HOME MESSAGES: Bicuspid aortic valve aortopathy is a distinct pathological process that may be complicated by physiologic athletic remodeling. Decisions on participation should adhere to established dimensional thresholds and guidelines, while being personalized within a shared decision-making framework and risk stratification. Following surgical intervention, a gradual, supervised return-to-play strategy, guided by postoperative imaging stability and multidisciplinary input, is necessary to ensure the safe resumption of athletic participation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.